UBS Group’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $506M | Sell |
|
|||||
|
2025
Q1 | $518M | Sell |
|
|||||
|
2024
Q4 | $451M | Buy |
|
|||||
|
2024
Q3 | $347M | Sell |
|
|||||
|
2024
Q2 | $309M | Buy |
|
|||||
|
2024
Q1 | $309M | Buy |
|
|||||
|
2023
Q4 | $288M | Buy |
|
|||||
|
2023
Q3 | $233M | Sell |
|
|||||
|
2023
Q2 | $259M | Buy |
|
|||||
|
2023
Q1 | $173M | Sell |
|
|||||
|
2022
Q4 | $243M | Buy |
|
|||||
|
2022
Q3 | $137M | Sell |
|
|||||
|
2022
Q2 | $176M | Buy |
|
|||||
|
2022
Q1 | $136M | Sell |
|
|||||
|
2021
Q4 | $245M | Sell |
|
|||||
|
2021
Q3 | $260M | Buy |
|
|||||
|
2021
Q2 | $220M | Sell |
|
|||||
|
2021
Q1 | $214M | Sell |
|
|||||
|
2020
Q4 | $205M | Sell |
|
|||||
|
2020
Q3 | $236M | Sell |
|
|||||
|
2020
Q2 | $300M | Sell |
|
|||||
|
2020
Q1 | $311M | Sell |
|
|||||
|
2019
Q4 | $346M | Buy |
|
|||||
|
2019
Q3 | $296M | Sell |
|
|||||
|
2019
Q2 | $324M | Buy |
|
|||||
|
2019
Q1 | $310M | Buy |
|
|||||
|
2018
Q4 | $289M | Sell |
|
|||||
|
2018
Q3 | $440M | Buy |
|
|||||
|
2018
Q2 | $323M | Buy |
|
|||||
|
2018
Q1 | $319M | Sell |
|
|||||
|
2017
Q4 | $357M | Sell |
|
|||||
|
2017
Q3 | $406M | Buy |
|
|||||
|
2017
Q2 | $318M | Sell |
|
|||||
|
2017
Q1 | $335M | Sell |
|
|||||
|
2016
Q4 | $404M | Sell |
|
|||||
|
2016
Q3 | $494M | Buy |
|
|||||
|
2016
Q2 | $421M | Sell |
|
|||||
|
2016
Q1 | $512M | Sell |
|
|||||
|
2015
Q4 | $721M | Buy |
|
|||||
|
2015
Q3 | $581M | Sell |
|
|||||
|
2015
Q2 | $744M | Buy |
|
|||||
|
2015
Q1 | $570M | Sell |
|
|||||
|
2014
Q4 | $693M | Buy |
|